Del Global Technologies’ acquisition of Villa Sistemi Medicali has proved valuable already. In January, Del Global obtained a 19% stake in Villa Sistemi along with the nonrevocable option to increase its share to 80%. In April, Del Global
Del Global Technologies acquisition of Villa Sistemi Medicali has proved valuable already. In January, Del Global obtained a 19% stake in Villa Sistemi along with the nonrevocable option to increase its share to 80%. In April, Del Global decided to exercise this option. (SCAN 5/10/00).
This month, the FDA gave Del Global approval to market Villa Sistemis Vision tilting table for radiographic and fluoroscopic examinations. The table is available in the U.S. and will be distributed by Del Global. Del Global is a Valhalla, NY-based designer, developer, and manufacturer of medical and dental imaging systems. Villa Sistemi is based in Milan, Italy.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
2 Commerce Drive
Cranbury, NJ 08512